THC Farmaceuticals Inc (CBDG)
0.043
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
THC Farmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2018 | 1.181 |
| March 31, 2018 | 1.166 |
| June 30, 2017 | |
| March 31, 2017 | |
| June 30, 2015 | 0.6747 |
| March 31, 2015 | 38.19 |
| December 31, 2014 | 0.1479 |
| September 30, 2014 | -1.618 |
| June 30, 2014 | -1.942 |
| March 31, 2014 | -2.106 |
| December 31, 2013 | -1.930 |
| September 30, 2013 | -3.392 |
| Date | Value |
|---|---|
| June 30, 2013 | -0.2107 |
| March 31, 2013 | -0.4683 |
| December 31, 2012 | -0.8778 |
| September 30, 2012 | 0.807 |
| June 30, 2012 | 0.2889 |
| March 31, 2012 | 0.1324 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.715M |
| Total Liabilities (Quarterly) | 0.701M |
| Shareholders Equity (Quarterly) | 1.014M |